There are several diagnostic tools, such as an electrocardiogram, echocardiogram, heart monitor, MRI, and other tests that cardiologists use to determine if a patient has hypertrophic cardiomyopathy. In addition to a physical exam, there are a number of heart monitoring devices available for diagnosing hypertrophic cardiomyopathy.
While hypertrophic cardiomyopathy has typically been recognized by its structure (hypertrophy), the electrical functions of the heart are also adversely affected.
In addition, all first-degree relatives of a patient with hypertrophic cardiomyopathy should be screened. This includes parents, siblings, children, and grandchildren.
Before giving any advice, the team gathers as much information as we can about your condition through the following diagnostic procedures:
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.